David Guzman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
David Guzman has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Artem Goncharov
Electrical & Computer Engineering Department, University of California, Los Angeles, USA
1 shared publication- Aydogan Ozcan
University of California
1 shared publication - Barath Palanisamy
Department of Bioengineering
1 shared publication Defne Yigci
Department of Mechanical Engineering, Koç University, Istanbul, Türkiye
1 shared publication- Dino Di Carlo
Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA
1 shared publication - Elliott Rogers
London Centre for Nanotechnology and Division of Medicine, University College London, London, UK
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 2 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-33
Machine learning in point-of-care testing: innovations, challenges, and opportunities
The landscape of diagnostic testing is undergoing a significant transformation, driven by the integration of artificial intelligence (AI) and machine learning (ML) into decentralized, rapid, and accessible sensor platforms for point-of-care testing (POCT). The COVID-19 pandemic has accelerated the shift from centralized laboratory testing but also catalyzed the development of next-generation POCT platforms that leverage ML to enhance the accuracy, sensitivity, and overall efficiency of point-of-care sensors. This Perspective explores how ML is being embedded into various POCT modalities, including lateral flow assays, vertical flow assays, nucleic acid amplification tests, and imaging-based sensors, illustrating their impact through different applications. We also discuss several challenges, such as regulatory hurdles, reliability, and privacy concerns, that must be overcome for the widespread adoption of ML-enhanced POCT in clinical settings and provide a comprehensive overview of the current state of ML-driven POCT technologies, highlighting their potential impact in the future of healthcare.
- 2 April 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-33
Top Cited PapersOpen AccessMachine learning in point-of-care testing: innovations, challenges, and opportunities
The landscape of diagnostic testing is undergoing a significant transformation, driven by the integration of artificial intelligence (AI) and machine learning (ML) into decentralized, rapid, and accessible sensor platforms for point-of-care testing (POCT). The COVID-19 pandemic has accelerated the shift from centralized laboratory testing but also catalyzed the development of next-generation POCT platforms that leverage ML to enhance the accuracy, sensitivity, and overall efficiency of point-of-care sensors. This Perspective explores how ML is being embedded into various POCT modalities, including lateral flow assays, vertical flow assays, nucleic acid amplification tests, and imaging-based sensors, illustrating their impact through different applications. We also discuss several challenges, such as regulatory hurdles, reliability, and privacy concerns, that must be overcome for the widespread adoption of ML-enhanced POCT in clinical settings and provide a comprehensive overview of the current state of ML-driven POCT technologies, highlighting their potential impact in the future of healthcare.
- Open Access
- 2 July 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (24) , 5367-5369
The NEW ESID online database network
Primary Immunodeficiencies (PIDs) belong to the group of rare diseases. The European Society for Immunodeficiencies (ESID) operates an international research database application for continuous long-term documentation of patient data. The system is a web application which runs in a standard browser. Therefore, the system is easy to access from any location. Technically, the system is based on Gails backed by MariaDB with high standard security features to comply with the demands of a modern research platform. The ESID Online Database is accessible via the official website: https://esid.org/Working-Parties/Registry-Working-Party/ESID-Registry. A demo system is available via: https://cci-esid-reg-demo-app.uniklinik-freiburg.de/EERS with user demouser and password Demo-2019.
- 2 July 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (24) , 5367-5369
Open AccessThe NEW ESID online database network
Primary Immunodeficiencies (PIDs) belong to the group of rare diseases. The European Society for Immunodeficiencies (ESID) operates an international research database application for continuous long-term documentation of patient data. The system is a web application which runs in a standard browser. Therefore, the system is easy to access from any location. Technically, the system is based on Gails backed by MariaDB with high standard security features to comply with the demands of a modern research platform. The ESID Online Database is accessible via the official website: https://esid.org/Working-Parties/Registry-Working-Party/ESID-Registry. A demo system is available via: https://cci-esid-reg-demo-app.uniklinik-freiburg.de/EERS with user demouser and password Demo-2019.